Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Carbohydrate metabolism]

A Iguchi1, H Miura, N Sakamoto

  • 1Department of Geriatric Medicine, Nagoya Univ. Sch. of Med.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility of 5-aminolaevulinic acid fluorescence-guided endoscopic biopsy for malignant mesothelioma in a cat and dog.

Australian veterinary journal·2022
Same author

Low prevalence of the 'gang of seven' and absence of the O80:H2 serotypes among Shigatoxigenic and enteropathogenic Escherichia coli (STEC and EPEC) in intestinal contents of healthy cattle at two slaughterhouses in Belgium in 2014.

Journal of applied microbiology·2017
Same author

Successful bone marrow transplantation in two sisters with activated phosphoinositide 3-kinase δ syndrome 2.

Bone marrow transplantation·2017
Same author

Identification of Shiga toxin-producing (STEC) and enteropathogenic (EPEC) Escherichia coli in diarrhoeic calves and comparative genomics of O5 bovine and human STEC.

Veterinary microbiology·2016
Same author

Effects of sitagliptin on plasma incretin concentrations after glucose administration through an esophagostomy tube or feeding in healthy cats.

Domestic animal endocrinology·2014
Same author

The TRIM-FLMN protein TRIM45 directly interacts with RACK1 and negatively regulates PKC-mediated signaling pathway.

Oncogene·2014

Advanced glycosylation end products (AGE), formed from glucose reactions with proteins, accumulate over time. These AGEs may accelerate atherosclerosis development by modifying proteins and interacting with cellular receptors.

Area of Science:

  • Biochemistry
  • Cardiovascular Research
  • Glycobiology

Background:

  • Non-enzymatic glucose reactions with proteins form Amadori products.
  • Amadori products slowly convert to advanced glycosylation end products (AGE).
  • AGEs are irreversible, brown, fluorescent protein cross-linkers accumulating on long-lived proteins.

Purpose of the Study:

  • To review advancements in glycosylation research pertinent to atherosclerosis.
  • To elucidate the role of AGEs in the pathogenesis of atherosclerosis.

Main Methods:

  • Literature review of glycosylation research.
  • Analysis of AGE formation and properties.
  • Examination of AGE interactions with biological molecules and receptors.

Related Experiment Videos

Main Results:

  • AGEs are formed through slow dehydration and rearrangement of Amadori products.
  • AGEs irreversibly modify proteins like collagen, lipoproteins, fibrinogen, and DNA.
  • A specific receptor for AGE-modified proteins has been identified on macrophages.

Conclusions:

  • AGEs accumulate on long-lived proteins, contributing to molecular damage.
  • AGE modification of proteins and interaction with macrophage receptors may accelerate atherosclerosis development.
  • Further research into glycosylation is crucial for understanding and potentially treating atherosclerosis.